Vonoprazan May Provide Better Results than PPIs in Helicobacter Pylori Eradication and Beyond - Is it Time for a Change?

J Gastrointestin Liver Dis. 2019 Dec 9;28(4):375-377. doi: 10.15403/jgld-573.

Authors

Matteo Ghisa¹, Brigida Barberio², Vincenzo Savarino³, Edoardo Savarino⁴

Affiliations

¹ Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy. . matteoghisa@yahoo.it.
² Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy. brigida.barberio@gmail.com.
³ Department of Internal Medicine, University of Genoa, Genoa, Italy. vsavarin@unige.it.
⁴ Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy. edoardo.savarino@unipd.it.

PMID: 31826049
DOI: 10.15403/jgld-573

No abstract available

Publication types

Editorial
Comment

MeSH terms

Helicobacter Infections*
Helicobacter pylori*
Humans
Proton Pump Inhibitors
Pyrroles
Sulfonamides

Substances

1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
Proton Pump Inhibitors
Pyrroles
Sulfonamides